Table 3.
Full model | Parsimonious model | ||||||
---|---|---|---|---|---|---|---|
Coef. | 95% CI | p | Coef. | 95% CI | p | ||
Disorder | |||||||
MDD | Ref. | ||||||
Dysthymia | −0.01 | −0.46 to 0.43 | |||||
Other mood disorder | 0.02 | −0.42 to 0.45 | |||||
Panic disorder | −0.10 | 0.42 to 0.21 | |||||
SAD | 0.12 | −0.28 to 0.53 | |||||
OCD | 0.52 | 0.01 to 1.03 | <0.05 | 0.76 | 0.36 to 1.15 | <0.001 | |
Other anxiety disorder | 0.32 | −0.30 to 0.95 | |||||
Recruitment from clinical samples only | 0.05 | −0.17 to 0.26 | |||||
Adults in general vs. specific target group | −0.41 | −0.70 to-0.13 | <0.01 | −0.27 | −0.50 to - 0.05 | <0.05 | |
Psychotherapy | |||||||
CBT | Ref. | ||||||
ITP | −0.16 | −0.45 to 0.12 | |||||
Counseling | −0.51 | −0.92 to −0.19 | <0.05 | −0.41 | −0.72 to −0.09 | <0.05 | |
Other therapy | −0.03 | −0.39 to 0.33 | |||||
Pharmacotherapy | |||||||
SSRI | Ref. | ||||||
TCA | 0.32 | 0.06 to 0.58 | <0.05 | 0.31 | 0.11 to 0.50 | <0.01 | |
MAOI | 0.07 | −0.34 to 0.48 | |||||
Other | −0.23 | −0.51 to 0.05 | |||||
Individual psychotherapy format | 0.01 | −0.27 to 0.28 | |||||
Number of psychotherapy sessions | 0.01 | −0.02 to 0.04 | |||||
Quality of study | 0.00 | −0.07 to 0.08 | |||||
Country | |||||||
USA | Ref. | ||||||
Europe | 0.26 | 0.03 to 0.49 | <0.05 | 0.18 | 0.00 to 0.36 | <0.05 | |
Other | −0.00 | −0.31 to 0.31 | |||||
Constant | 0.31 | −0.29 to 0.91 | 0.09 | −0.12 to 0.29 |
MDD – major depressive disorder, SAD – social anxiety disorder, OCD – obsessive-compulsive disorder, CBT – cognitive-behavioral therapy, ITP – interpersonal psychotherapy, SSRI – selective serotonin reuptake inhibitor, TCA – tricyclic antidepressant, MAOI – monoamine oxidase inhibitor